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Abstract Anterior cruciate ligament (ACL) rupture, one of
the most common knee injuries in sports, results in
anteroposterior laxity, which often leads to an unstable
knee. Traditional ACL reconstruction is performed with
autograft; disadvantages of this technique are donor site
morbidity and a long rehabilitation period. In the 1980s,
artificial ligaments became an attractive alternative to
biological grafts. The initial enthusiasm surrounding their
introduction stemmed from their lack of donor morbidity,
their abundant supply and significant strength, immediate
loading and reduced postoperative rehabilitation. Syn-
thetic grafts made of different materials such as carbon
fibers, polypropylene, Dacron and polyester have been
utilised either as a prosthesis or as an augmentation for a
biological ACL graft substitute. Nevertheless, every
material presented serious drawbacks: cross-infections,
immunological responses, breakage, debris dispersion
leading to synovitis, chronic effusions, recurrent insta-
bility and knee osteoarthritis. Recently, a resurgence of
interest in the use of synthetic prostheses has occurred
and studies regarding new artificial grafts have been
reported. Although many experimental studies have been
made and much effort has been put forth, currently no
ideal prosthesis mimicking natural human tissue has been
found.
Introduction
Anterior cruciate ligament (ACL) reconstruction is com-
monly performed to restore knee stability after ACL
rupture. Several methods have been proposed for the
treatment of ACL deficient knee, but controversy exists
about the best procedure. For intra-articular reconstruction
the patellar tendon [1–3], the iliotibial tract [4] and the
hamstring tendons [5] are commonly used. However,
autologous grafts have some well-recognised drawbacks
related to donor site morbidity and delayed return to sports
[6, 7]. Allograft tendons are reported to have excellent
clinical results, but these grafts bring the risk of infection
and disease transmission and sterilisation could cause a
weakening of the tissue in comparison to the native ACL.
For these reasons their use has been confined to ACL
revision surgery [8, 9]. In order to overcome such
inconveniences, the use of synthetic ligaments for ACL
reconstruction became popular in the 1980s and early
1990s. The initial enthusiasm about the introduction of
artificial ligaments stemmed from their lack of harvest site
pathology, their abundant supply and significant strength,
the technically easier surgical technique and the accelerated
rehabilitation period. Different procedures and various
materials have been employed throughout the years and
contributed to the diffusion of artificial ligaments as a
therapeutic option in knee surgery.
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Artificial materials
The beginning: carbon fibres
The advent of artificial ligaments dates back to the beginning
of the 20th century, when silver and stainless wires, nylon
and silk strings and various synthetic fibres were used to
create artificial grafts [10]. However, the unsatisfactory
results and the high rate of early ruptures confined these
initial attempts to the stage of animal experiments, and these
materials were never adopted in clinical trials.
In the 1970s the interest for synthetic grafts led to their
introduction as substitutes for biological human tissue. The
increased appeal of these supports resulted in the commer-
cialization of products such as Proplast ligaments (Vitex-
Inc, Houston, TX, USA) made of Teflon and carbon and
Polyflex (Richard, Memphis, TN, USA) made of polypro-
pylene. Results were scarce for both methods which had to
be withdrawn from the market due to their high rupture rate
and inflammatory reaction in the surrounding tissues.
Experimental studies conducted on these materials showed
their unsuitable mechanical properties.
In 1977, Jenkins et al. [11] developed an artificial
ligament made of carbon fibre (Intergraft, Osteonics
Biomaterials, Livermore, CA, USA). After being initially
employed for tendon sutures, its use was then extended to
ligament reconstruction in the knee and other joints.
In 1981, Dandy et al. first implanted a carbon-fibre
reinforced substitute for ACL with an arthroscopic
procedure [12].
However, after preliminary encouraging results, serious
sequelae were observed during clinical application. It has
been demonstrated that the poor resistance to torsion forces
caused an early rupture of the fibres leading to carbon
deposits in the liver and inflammatory synovitis in the knee
joint [13].
Neither the subsequent attempt to combine this material
with autologous tissue nor the association with bio-
adsorbable polymers on the ligament surface could prevent
the significant side effects associated with these grafts. For
this reason these materials were completely abandoned.
Gore-Tex
As carbon fibres were overtaken and surgeons increasingly
performed ACL reconstruction arthroscopically, newmaterials
came in.
In 1986, ligaments made by expanded polytetrafluor-
ethylene (PTFE) (Gore-Tex, W.L.Gore, Flagstaff, AR, USA),
a material already adopted in vascular surgery, were approved
in the United States by the Food and Drug Administration
(FDA) for the use in patients with previously failed autologous
ACL reconstructions.
The Gore-Tex ligament is made by a single strand of
PTFE wounded into multiple loops. It was designed as a true
prosthesis and implanted to permanently replace the natural
ACL [14]. It was supposed to promote immediate fixation
and early load-bearing capacity. These grafts have an
ultimate tensile strength of 5300 N, higher than any other
commercial artificial ligament [15]. It should be noted that a
natural ACL has a tensile strength of 630 N in adults [16]
and 1730 N in the young population [17] (Table 1). In
addition, its stiffness of 322 N/mm and its ultimate strain of
9% confer to the graft an excellent postoperative stability
immediately and an early load-bearing capacity; thus
explaining their initial spread as first reports in 1983
documented their encouraging short-term results.
Ahlfeld et al. [18] followed 30 patients with a Gore-Tex
ACL graft, and two years after the implant documented
only one prosthetic breakage. Glousman et al. [19] reported
a prospective study on the implant of 82 PTFE ligaments
with an 18 month follow-up (range 12–30), noticing an
immediate improvement of objective and subjective para-
meters. Complications included four ruptures, seven major
complications (8%) and 14 revision operations (17%).
Similar results were reported by Woods et al. [20] in a two-
year follow-up on 33 patients. After preliminary good results,
they observed a worsening in knee stability. Ahlfeld et al. [21]
followed up 30 patients with a Gore-Tex ACL graft and two
years after the implant observed only one prosthetic breakage.
Similarly, Friedman [22] reported the results of 103 Gore-Tex
ACL ligaments with a follow-up of 16 months documenting
only three ruptures. Using the same graft material, Ferkel et al.
[23] performed 21 second look arthroscopies 11 months after
surgery and found the ligament partially damaged in six knees
and completely ruptured in four cases.
Soon, mechanical properties of these grafts were
recognised as unsuitable, as failures were related to
mechanical fatigue due to the lack of tissue ingrowth and
to the presence of wear debris.
With a two-year follow-up after the implantation of 41
Gore-Tex ligaments, Indelicato et al. [24] stressed the
possibility that these devices were susceptible to breakage
and correlated the findings of synovial reaction found in
nine patients to the presence of PTFE particles. Paulos et al.
[25] noted an improvement of subjective and objective
criteria in less then 50% of the 188 patients followed-up for
four years, reporting a total complication rate of 76% in
patients that had already previously undergone ACL
reconstruction. Sledge et al. [26] reported a rupture rate of
29% in their five-year follow-up and discouraged future
implantation of these devices. Two cases of tunnel
osteolysis were described by Seemann and Steadman [27]
with the finding of a progressive tunnel enlargement
leading to late failure. Wilson et al. [28] described an
inguinal limphoadenopathy in two patients after Gore-Tex
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ligament implantation in the knee joint. Microbiological
and hystological examinations demonstrated the presence
of PTFE particles in the lymphonode, proving the occur-
rence of complications in sites distant from the knee.
The Gore-Tex graft was withdrawn from the market in
1993 as well as the Gore-Tex CD, the second-generation
ligament. Since then the use of this material has been
completely abandoned in knee instability surgery.
Dacron
A different approach in the development was adopted for
the Dacron ligament (Meadox Medicals, Oakland, NJ,
USA; Stryker Corp., Kalamazoo, MI, USA), initially
employed in acromio-clavicular joint injuries and in tendon
reconstructions. This ligament, approved in 1989 in the
United States by the FDA, is made of polyester and is
designed to replace the ACL permanently. The graft is
composed of an 8-mm diameter sleeve of loosely woven
velour with a central core made of four tightly woven tapes.
It has a mean ultimate tensile strength of 3,631 N and a
mean ultimate elongation of 18.7% [15, 29] (Table 1).
Initial reports have shown encouraging results in the
short term. A study by Lukianov et al. [29] reported the
results at a mean follow-up of 28 months in 41 patients who
underwent ACL reconstruction with a Stryker Dacron
ligament prosthesis. In 75% of the patients Lachman,
anterior drawer, and pivot shift tests were found negative.
However, in 1991, Arnauw et al. [30] studied 57 patients
with an ACL Dacron prosthesis and observed a rupture rate
of 40% 18 months after surgery.
Wilk and Richmond [31] described the five-year results
after the implantation of 84 Dacron ligaments in which the
failure rate was 35.7%. This represented a dramatic increase
compared to the 20% failure rate reported at the two-year
follow-up. With the same artificial ligaments, Gillquist and
Odensten [32] reported a five-year follow-up of 69 patients.
They noticed only two cases of mild synovitis, but a high
percentage of revisions (34%) and a high level of ante-
roposterior (AP) laxity. In 1997, presenting their long-term
results, they described an increased rupture rate with 29% of
the patients who underwent revision surgery. Eighty-three
percent of the patients had documented radiographic degen-
erative osteoarthritis and only 14% had an acceptable stability
and functional outcome. Noble [33] presented the results of
110 patients after having implanted a Dacron ACL graft with
a follow-up of two to five years. He noticed a complication
rate of 30%, with 12 ruptures and 19 cases of significant
synovitis. Barrett et al. [34] reviewed 40 patients after
implantation of Dacron prostheses, reporting a rupture rate
of 60%, and found the suitability of the material unfavour-
able. In their paper, Maletius and Gillquist [35] evaluated the
osteoarthritis grading in 52 patients nine years after the
implantation of Dacron ligaments and detected a narrowing
of the joint space greater than 50% (grade II according to
Ahlbäck classification) in 40% of the patients.
This product was withdrawn from the market by Striker
in 1994.
Kennedy LAD and the “augmentation” concept
The introduction of the Kennedy Ligament Augmentation
Device (LAD; 3M, St. Paul, MN, USA) in 1975 by Dr. John
Kennedy, made an important change in the history of artificial
grafts.
It consisted of an 8-mm diameter ribbon of polypropyl-
ene woven with an ultimate tensile strength of 1,730 and a
stiffness of 56 N/mm [15]. It was implanted in knee
ligament surgery in addition to an autologous ACL
reconstruction or after ACL primary repair and was
designed to provide protection to the healing ACL or
autologous graft. In fact its mechanical profile, much
inferior to other artificial ligaments, was conceived to
transfer loads during initial healing process and to protect
the autologous implant during its early phase of vascular-
isation and collagen maturation.
In this surgical procedure (the so-called “augmentation”),
the role of the autologous component can be played by several
tissues, such as bone-patellar-tendon-bone graft (BPTB),
hamstrings, and ilio-tibial tract.
By creating a composite structure, the artificial component
plays the role of a load-carrier while it progressively transfers
load to the healing neo-ligament, protecting the biological
transplant from potentially damaging precocious loads.
Roth et al. [36] presented the results of a Marshall-
MacIntosh technique reinforced with LAD and documented
significant improvements in terms of stability and func-
tional outcome. Del Pizzo [37], in his three-year follow-up
paper on patients who underwent ACL reconstruction with
LAD, documented negativity to Pivot-shift test in 95% of
the patients and AP laxity less than 3 mm in 72%. The
rupture rate was 1.4%.
Table 1 Mechanical properties of synthetic grafts compared to natural ligaments
Properties Natural ligament Carbon fibre Gore-Tex Dacron Kennedy-LAD Trevira Leeds-Keio
Ultimate tensile strength (N) 1730 660 5300 3631 1500 1866 2000
Stiffness (N/mm) 182 230×109 322 420 280 68.3 270
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All studies stress the importance of the biocompatibility
of the material, but its use as an ACL substitute has not
been recommended.
Polyester
Apart from polypropylene, the only materials implanted in
recent years were polyester composites, like Proflex (Protek
Ltd, Bern, Switzerland) and Trevira-hochfest (Telos, SARL,
Marburg, Germany), the latter being the most long-lived in
terms of use by orthopaedic surgeons.
Proflex was conceived by Mansat [38] in France in 1985
and implanted for chronic knee instability with an “over the
top” technique. According to this procedure already
reported by Kennedy, a free transplant of the central third
of the patellar tendon is introduced into the femoral tunnel,
while the artificial ligament is fixed proximally to the
external femoral cortex by a staple. Both components are
then introduced and fixed in the tibial tunnel. The
implantation through the “over the top” technique demon-
strated a reduction of tunnel abrasion and consequently less
wear particles in the joint cavity. Nevertheless, follow-ups
demonstrated several complications including arthrosyno-
vites, early breakage, and tunnel osteolysis.
The Trevira ligament has been implanted since 1980. It has
good mechanical properties (ultimate tensile strength of
1,866 N, stiffness 68,3 N/mm[39]) and a reduced water
adsorption capacity (<0.04 vol %) (Table 1). Its first use was
in the cervical spine for stabilisation procedures. Subsequent-
ly adapted as a ligament for the knee joint, it has been used as
a prosthesis or as an augmentation together with an
autologous transplant.
Both animal and clinical trials showed a reduced
breakage rate and minor inflammatory responses compared
to other materials.
In 1988 in Milan, a small ligament (30-mm long and
10-mm thick) made of polyethylene terephtalate was deve-
loped; it was called Pro-Pivot and implanted as an augment to
a BPBT graft with an “over the top” technique [40]. The study
conducted in 1991 by Lanzetta et al. on 130 sportsmen who
underwent ACL Pro-Pivot replacement showed good results
in terms of joint stability. Second-look arthroscopies at six, 12
and 24 months after surgery demonstrated a process of
integration of the artificial ligament that appeared complete
two years after its implantation [40].
Showing the results eight years after the implantation of 160
artificial Trevira-hochfest devices using an over the top
technique, Krudwig [41] demonstrated good results in terms
of patient satisfaction andAP stability (only 16% of the patients
showed an anterior sub-luxation >5 mm). Radiographic signs
of osteoarthritis were found only in patients with previous
history of meniscal surgery. The author suggested that synthetic
prostheses do not invariably induce knee arthritis.
In the 1980s the marketing system led to a wide diffusion of
polyester grafts and many synthetic ligaments were produced
in Europe, including Ligastic (Orthomed, Marsannay La Côte,
France) and SEM (Science et Médecine, Montrouge, France).
The early failures of these prostheses, together with many
other prototypes, were microscopically analysed in a retro-
spective study by Guidoin et al. [42]. The authors report that
failure was related to inadequate resistance to abrasion and
torsion forces, together with structural changes of the grafts
due to unpredictable tissue infiltration.
After analysing 33 ruptured ABC grafts (Surgicraft Ltd,
Redditch, UK) with scanning electron microscopy, Mowbray
et al. correlated the high incidence of early prosthetic ligament
failures to the abrasion of the ligament at the tibial tunnel exit.
The authors found that artificial implants are particularly
vulnerable to rupture if an impingement occurs [43].
Similarly, Amis and Kempson reported the failure
mechanisms of Apex ligaments (DePuy International,
Leeds, UK) and confirmed the hypothesis that bone
impingement at the tibial tunnel exit leads to synthetic
fibre damage [44].
Leeds-Keio: promoting tissue ingrowth
The Leeds-Keio (LK) ligament (Neoligaments Ltd, Leeds,
UK) was developed in 1982 from the collaboration between
the University of Leeds (UK) and the Keio University
(Japan) [45]. It is made by woven polyester fibers
constituting a tubular bundle measuring 10 mm in diameter.
It has been used for ACL reconstruction and in other types
of reconstructive surgery. Over 50,000 LK grafts have been
implanted worldwide.
The LK ligament is a “scaffold” type of prosthesis, as it acts
as an inducer for tissue ingrowth; porous coating allows the
induction of biological tissue and promotes the formation of a
neo-ligament on the intra-articular portion [46]. Without
rehabilitation, its tensile strength is approximately 850 N;
by the developing of tissue ingrowth, a maximum tensile
strength of 2000 N has been demonstrated; its stiffness has
been measured as 270 N/mm, which is similar to a natural
ligament [45] (Table 1).
Denti et al. [47] reported their results after an average
period of 33 months from the implantation of LK ligaments
on 26 patients. They noticed an improvement in subjective
and objective parameters and two cases of rupture.
Fujikawa [45] reviewed 152 patients after a follow-up of
more than four years: 90.1% had a negative Lachman test
and 82.2% a negative anterior drawer sign; no major
complications were noticed. Second-look arthroscopies
performed three and six months after surgery reported a
good coverage of the implanted ligament; ruptures occurred
only in 3.3% of cases. Rading and Peterson [48] reported
the results of 24 cases treated with a LK artificial ligament
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two years after implantation; only eight patients had a
subjectively stable knee and 37.5% were objectively
unstable. Engstrom et al. [49] compared LK to autologous
patellar tendon graft (TR) in a prospective randomised
study including 26 TR and 29 LK after an average follow-
up of 28 months; the authors noticed in the LK group an
increased anterior laxity and positivity to pivot-shift test.
Murray and Macnicol [50] reported long-term follow-up
results ten to 16 years after LK ACL reconstruction.
Twenty-eight percent were found to have ruptured their
ligament and all postoperative knees had increased degene-
rative changes compared with their opposite joint. The
authors found that LK ligaments do not give satisfactory
guarantees in ACL reconstruction.
Artificial ligaments as an iatrogenic model of osteoarthritis
in the human knee
The 1990s were characterised by a loss of trust by orthopaedic
surgeons in artificial ligaments implantation. The findings of
complications during the first decade of use of these materials
(breakage, wear debris, synovitis, recurrent instability, osteo-
lysis and chronic effusions) forced the abandonment of
synthetic grafts [27, 29, 32, 34, 35].
The effect of wear debris has been studied using animal
models at Pittsburgh University. Olson et al. reported the in
vivo and in vitro behaviour of seven artificial ligaments on
synovial cells; the foreign-body reaction induced by the
synthetic particles led to giant cell aggregation and synovial
hypertrophy close to the wear debris [51]. All grafts were
associated with increased expression of cytokines such as
interleukin-1 (IL-1) and various metalloproteinases
(MMPs), including gelatinases and collagenases. These
MMPs are involved in the unbalanced matrix degradation
process that initiates cartilage degeneration in osteoarthritis
[52]. Studies demonstrate that the inflammatory reaction
caused by wear particles of a foreign body leads to peculiar
modification in the composition of the synovial fluid: the
protein concentration within the synovial fluid increases in
response to synovitis signalling reactions [53]. The deple-
tion of cartilage matrix that follows is responsible for the
development of osteoarthritis.
In their paper Olson et al. first suggested the possibility
that artificial ligaments could induce osteoarthritis in the
knee joint instead of preventing it [51].
In 1992, when analysing the results four years after the
implantation of 55 Dacron ligaments, Klein and Jensen [54]
noted that this material can act as an inducer in the
development of osteoarthritis in the knee joint and that
artificial grafts are essentially “an iatrogenic model of
degenerative arthritis in the human knee”. The authors
recommended the orthopaedic community not use any
artificial support in ACL surgery.
Recently, Ventura et al. [55] evaluated prospectively the
outcome of ACL reconstruction using polyethylene tere-
phthalate (PET) artificial ligaments in sportsmen, with a
follow-up extending to 19 years. They reported a high rate
of degenerative osteoarthritis in all patients and suggested
that artificial ligaments could contribute to the establish-
ment of the degenerative osteoarthritic process.
Synthetic grafts in the year 2000: LARS artificial ligaments
Despite the discouraging results and loss of confidence by
the scientific community in the use of synthetic materials,
recently a resurgence of interest in the use of artificial
ligaments has occurred since some studies indicate that,
under particular conditions, artificial ACL reconstruction
can be successful [56, 57].
Lavoie et al. [56] reported their results after the
implantation of LARS ligaments (Ligament Advanced
Reinforcement System, Surgical Implants and Devices,
Arc-sur-Tille, France). These ligaments are made of
polyethylene terephtalate and their structure allows tissue
ingrowth in the intra-articular part.
The follow-up made on 47 patients, eight to 45 months
after implantation, showed good average results according
to subjective parameters (average KOOS score 93), and a
satisfying Tegner activity level. A subsequent study from
the same scientific group compares two-year results after
LARS ligament ACL reconstruction with the BPTB graft
technique [57]. Their findings were that the LARS ligament
gave better subjective and objective outcomes during the
initial years, while no difference with the autologous
procedure could be found 24 months after surgery.
In a retrospective study, Liu et al. compared LARS artificial
ligaments to four-strand hamstring tendon autografts four
years after implantation. They observed excellent functional
outcomes, with a higher knee stability in the LARS group
[58].
Studies advocate that LARS ligament reconstruction
could lead to an early return to high activity levels,
although long-term results are still required.
Conclusions and future directions
The study and analysis of failures in artificial ligament
history has put the basis for future research and studies on
finding a synthetic substitute with the best physical and
chemical properties [59].
Research in the field of artificial ligaments demonstrates
that the ultimate characteristic required for these materials is
biocompatibility (chemical stability, degree of polymeriza-
tion, absence of soluble additives, scarce water adsorption,
presence of pores for fibroblasts ingrowth); on the other
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hand, mechanical characteristics (traction resistance, stiff-
ness, elongation, torsion and abrasion resistance) should be
as similar as possible to those of the natural ligament.
In order to succeed, tissue engineering should provide a
functional and biologically valid ACL, able to promote a
continuous tissue remodelling.
Despite much effort and many experimental studies,
every material has been found to have several drawbacks,
and research to find the ideal substitute, mimicking the
natural human tissue, is still ongoing.
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